Literature DB >> 1404800

Gene therapy for cancer.

S A Rosenberg1.   

Abstract

Entities:  

Keywords:  Genetics and Reproduction; National Institutes of Health

Mesh：

Substances：

Year:  1992        PMID： 1404800

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Development of effective immunotherapy for the treatment of patients with cancer.

Authors:  Steven A Rosenberg
Journal:  J Am Coll Surg       Date:  2004-05       Impact factor: 6.113

2.  Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.

Authors:  Sid P Kerkar; Luis Sanchez-Perez; Shicheng Yang; Zachary A Borman; Pawel Muranski; Yun Ji; Dhanalakshmi Chinnasamy; Andrew D M Kaiser; Christian S Hinrichs; Christopher A Klebanoff; Christopher D Scott; Luca Gattinoni; Richard A Morgan; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunother       Date:  2011-05       Impact factor: 4.456

Review 3.  From in vitro to in vivo. Progress in the use of cultured cells for human therapy.

Authors:  W Dalemans
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Interventional genetics and cancer treatment.

Authors:  N R Lemoine; K Sikora
Journal:  BMJ       Date:  1993-03-13

5.  Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes.

Authors:  Steven A Rosenberg; Mark E Dudley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

6.  The development of gene therapy for the treatment of cancer.

Authors:  S A Rosenberg; W F Anderson; M Blaese; P Hwu; J R Yannelli; J C Yang; S L Topalian; D J Schwartzentruber; J S Weber; S E Ettinghausen
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

Review 7.  Current treatment options for malignant melanoma.

Authors:  G L Cohen; C I Falkson
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 8.  Gene therapy in surgical oncology.

Authors:  S P Gagandeep; G J Poston; A R Kinsella
Journal:  Ann Surg Oncol       Date:  1995-03       Impact factor: 5.344

9.  Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.

Authors:  F M Marincola; S Ettinghausen; P A Cohen; L B Cheshire; N P Restifo; J J Mulé; S A Rosenberg
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

Review 10.  Cancer gene therapy: principles, problems, and perspectives.

Authors:  F Herrmann
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.